|Articles|March 1, 2016
- Pharmaceutical Executive-03-01-2016
- Volume 36
- Issue 3
Pharmaceutical Executive, March 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Beyond 2020: Building Strategic Coherence in the New Health Economyabout 10 years ago
What Errors Do We Miss in Clinical Trials?about 10 years ago
Data Disclosure: Sealing the Error Envelopeabout 10 years ago
Vaccines 2016: Big Bets for Global Threatsabout 10 years ago
Drug Delivery Roundtable: More than the Pillabout 10 years ago
Orphans of the Stormabout 10 years ago
Country Report: The NetherlandsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
3
What Are the ‘Last Mile Issues’ Impacting Pharma?
4
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
5